NCT01622283View on ClinicalTrials.gov

Pharmacokinetic Study of Levocetirizine Oral Solution

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 2, 2012

Primary Completion Date

June 10, 2012

Study Completion Date

June 10, 2012

Conditions

Rhinitis, Allergic, Perennial and Seasonal

Interventions

DRUG

Levocetirizine

Levocetirizine

DRUG

Cetirizine

Cetirizine

Trial Locations (1)

890-0081

GSK Investigational Site, Kagoshima

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01622283 - Pharmacokinetic Study of Levocetirizine Oral Solution | Biotech Hunter | Biotech Hunter